Watanabe, S., Yonesaka, K., Tanizaki, J., Nonagase, Y., Takegawa, N., Haratani, K., . . . Nakagawa, K. Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer. Wiley.
Chicago Style (17th ed.) CitationWatanabe, Satomi, et al. Targeting of the HER2/HER3 Signaling Axis Overcomes Ligand‐mediated Resistance to Trastuzumab in HER2‐positive Breast Cancer. Wiley.
MLA (9th ed.) CitationWatanabe, Satomi, et al. Targeting of the HER2/HER3 Signaling Axis Overcomes Ligand‐mediated Resistance to Trastuzumab in HER2‐positive Breast Cancer. Wiley.
Warning: These citations may not always be 100% accurate.